A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
Pfizer is in discussions with the Indian government seeking an “expedited approval pathway” for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he said.
“We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.”
Our Standards: The Thomson Reuters Trust Principles.
Peli Products has launched the Peli™ 9730 Remote Area Lighting System, a next-generation portable lighting…
Polaris Inc. is set to revive its popular Free Snowmobile Rides program in February 2026
Slone Partners has appointed George Quinn as Partner, Fractional Talent, strengthening its focus on flexible
Hanshow has appointed Philippe Brochard as Chairman of its Advisory Committee, strengthening the company’s governance…
Tiiny AI’s Pocket Lab makes headlines at CES 2026 with a pocket size personal AI…
Study by fäm Luxe highlights how Dubai has built ecosystem designed to attract and retain…